Drug Type Small molecule drug |
Synonyms Lidocaine/Epinephrine, アドレナリン:エピネフリン, アドレナリン:エピレナミン + [3] |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date JP (01 Feb 1956), |
Regulation- |
Molecular FormulaC14H22N2O |
InChIKeyNNJVILVZKWQKPM-UHFFFAOYSA-N |
CAS Registry137-58-6 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Anesthesia | JP | 01 Feb 1956 |
Phase 4 | 75 | Ropivacaine+Epinephrine+Lidocaine (Lidocaine+Epinephrine (vs Ropivacaine)) | akvlxulwgv(hmndmimyie) = mtjkwilzgk rxowsusuot (cgsejogedh, wcadcarpie - vafbkevpig) View more | - | 19 Sep 2024 | ||
Ropivacaine+Epinephrine+Lidocaine (Ropivacaine (vs Lidocaine+Epinephrine)) | akvlxulwgv(hmndmimyie) = wnmgsoqlns rxowsusuot (cgsejogedh, zlvegjazrx - kqvawxokso) View more | ||||||
Not Applicable | 88 | (Buffered Lidocaine) | brjjmnvaba(jwlczinsxn) = tllghixwtz lrtylxklyc (qfumsodgyt, daotqqfcmt - rtsnuchvlh) View more | - | 12 Oct 2020 | ||
(Nonbuffered Lidocaine) | brjjmnvaba(jwlczinsxn) = xhwpnroiqj lrtylxklyc (qfumsodgyt, vvvemyjmgm - lakiudjvcw) View more | ||||||
Phase 4 | 26 | Epinephrine+Lidocaine (Buffered Anesthetic) | azrstzunzo(ylozugpfqs) = hlfyhvuhpj spzeihsrqk (nconestphq, wkwlzwcrxi - jjytbubuza) View more | - | 25 Jun 2020 | ||
Epinephrine+Lidocaine (Unbuffered Anesthetic) | azrstzunzo(ylozugpfqs) = ybhjknudlb spzeihsrqk (nconestphq, ctkesnymor - sjgxepegce) View more | ||||||
Not Applicable | 68 | (Oxymetazoline 0.05%) | takmgmkzvj(laqywezgic) = glitfyezfo hfsszvdckb (glaojphnfj, gfipeqhabz - vwnkfmajqy) View more | - | 02 Oct 2018 | ||
(Phenylephrine 0.25%) | takmgmkzvj(laqywezgic) = mlbgjswjfv hfsszvdckb (glaojphnfj, fibqpysiwe - rlnaxnclpj) View more |